tiprankstipranks
Rani Therapeutics Holdings (RANI)
NASDAQ:RANI
US Market

Rani Therapeutics Holdings (RANI) Income Statement

Compare
1,113 Followers

Rani Therapeutics Holdings Income Statement

Last quarter (Q3 2024), Rani Therapeutics Holdings's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Rani Therapeutics Holdings's net income was $-6.78M. See Rani Therapeutics Holdings’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 0.00$ 0.00$ 2.72M$ 462.00K$ 979.00K
Gross Profit
$ -822.00K$ -1.31M$ 2.72M$ 462.00K$ 979.00K
Operating Expenses
$ 66.10M$ 63.45M$ 54.32M$ 17.01M$ 28.04M
Depreciation and Amortization
$ 822.00K$ 1.31M$ 497.00K$ 589.00K$ 564.00K
EBITDA
$ -65.28M$ -60.89M$ -52.08M$ -15.96M$ -26.01M
Operating Income
$ -66.10M$ -63.45M$ -51.60M$ -16.54M$ -27.07M
Other Income/Expenses
$ -1.78M$ 177.00K$ -1.45M$ -124.00K$ 478.00K
Pretax Income
$ -67.88M$ -63.27M$ -53.05M$ -16.67M$ -26.59M
Net Income
$ -33.97M$ -63.34M$ -53.09M$ -16.70M$ -26.60M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -1.33$ -2.66$ -2.69$ -0.85$ -1.35
Diluted EPS
$ -1.33$ -2.66$ -2.69$ -0.85$ -1.35
Weighted Average Shares Outstanding
25.50M 23.82M 19.71M 19.74M 19.74M
Weighted Average Shares Outstanding (Diluted)
25.50M 23.82M 19.71M 19.74M 19.74M
Currency in USD

Rani Therapeutics Holdings Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis